Amylyx Pharmaceuticals
AMLX
AMLX
177 hedge funds and large institutions have $1.36B invested in Amylyx Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 70 increasing their positions, 44 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $1.49B → $1.36B (-$135M)
20.82% less ownership
Funds ownership: 123.05% → 102.23% (-21%)
33% less funds holding in top 10
Funds holding in top 10: 9 → 6 (-3)
Holders
177
Holding in Top 10
6
Calls
$6.39M
Puts
$1.21M
Top Buyers
| 1 | +$69.8M | |
| 2 | +$26.2M | |
| 3 | +$26M | |
| 4 |
CC
Commodore Capital
New York
|
+$21.4M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$16.3M |
Top Sellers
| 1 | -$54.9M | |
| 2 | -$33.3M | |
| 3 | -$25.8M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$16.2M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$11.7M |
